LactSafeFor educational purposes only — always consult your healthcare provider.
🤱 Breastfeeding Safety
Adalimumab
Humira
Adalimumab is considered safe during breastfeeding. It produces low levels in breastmilk and is likely minimally absorbed by the infant.
Want the full details?
- Detailed reasoning behind this rating
- Effect on milk supply
- Infant side effects to watch for
- Safer alternatives
Free · No account required